These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Abnormal expression pattern of the ASPP family of proteins in human non-small cell lung cancer and regulatory functions on apoptosis through p53 by iASPP. Li S, Shi G, Yuan H, Zhou T, Zhang Q, Zhu H, Wang X. Oncol Rep; 2012 Jul; 28(1):133-40. PubMed ID: 22552744 [Abstract] [Full Text] [Related]
3. [Expression of ASPP gene family and its relationship with survival of patients with non-small cell lung cancer]. Su M, Gu Y, Su S, Lu B. Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):268-72. PubMed ID: 24989912 [Abstract] [Full Text] [Related]
4. Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Zhao J, Wu G, Bu F, Lu B, Liang A, Cao L, Tong X, Lu X, Wu M, Guo Y. Hepatology; 2010 Jan; 51(1):142-53. PubMed ID: 20034025 [Abstract] [Full Text] [Related]
5. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study. Xie XF, Yang Q, Chi J, Yang XZ, Wang HY, Xu GL. Chin J Cancer; 2017 Jan 19; 36(1):15. PubMed ID: 28103919 [Abstract] [Full Text] [Related]
6. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation. Wang X, Cheng Y, Zhu Y, Li H, Ge W, Wu X, Zhao K, Yuan J, Li Z, Jiang S, Han Z, Jiang Q, Wu Q, Liu T, Zhang C, Yu M, Hu Y. Int J Cancer; 2017 Oct 01; 141(7):1422-1433. PubMed ID: 28656647 [Abstract] [Full Text] [Related]
8. Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer. Kim DH, Nelson HH, Wiencke JK, Christiani DC, Wain JC, Mark EJ, Kelsey KT. Oncogene; 2001 Mar 29; 20(14):1765-70. PubMed ID: 11313923 [Abstract] [Full Text] [Related]
9. p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma. Mori S, Ito G, Usami N, Yoshioka H, Ueda Y, Kodama Y, Takahashi M, Fong KM, Shimokata K, Sekido Y. Cancer; 2004 Apr 15; 100(8):1673-82. PubMed ID: 15073856 [Abstract] [Full Text] [Related]
10. Apoptosis stimulating protein of p53 (ASPP) 1 and ASPP2 m-RNA expression in oral cancer. Patel KD, Barasiya YV, Patel JB, Patel PS. Arch Oral Biol; 2020 Nov 15; 119():104920. PubMed ID: 32987288 [Abstract] [Full Text] [Related]
11. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer]. Yang Q, Zhu RQ, Fang Z, Xia D, Diao LM, Liu MQ. Ai Zheng; 2005 Mar 15; 24(3):321-6. PubMed ID: 15757534 [Abstract] [Full Text] [Related]
12. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer. Hsu HS, Wang YC, Tseng RC, Chang JW, Chen JT, Shih CM, Chen CY, Wang YC. Clin Cancer Res; 2004 Jul 15; 10(14):4734-41. PubMed ID: 15269146 [Abstract] [Full Text] [Related]
13. [Study on expression and methylation of caveolin 1 gene in non-small cell lung cancers]. Zhang YX, Chen HL, Ye B, Yang F, Yu LY. Zhonghua Bing Li Xue Za Zhi; 2008 May 15; 37(5):300-4. PubMed ID: 18956646 [Abstract] [Full Text] [Related]
14. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT. Cancer Res; 2001 Apr 15; 61(8):3419-24. PubMed ID: 11309302 [Abstract] [Full Text] [Related]
15. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status. Wu JY, Wang J, Lai JC, Cheng YW, Yeh KT, Wu TC, Chen CY, Lee H. Ann Surg Oncol; 2008 Nov 15; 15(11):3272-7. PubMed ID: 18712569 [Abstract] [Full Text] [Related]
16. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer. Zhang Y, Miao Y, Yi J, Wang R, Chen L. Clin Lung Cancer; 2010 Jul 01; 11(4):264-70. PubMed ID: 20630829 [Abstract] [Full Text] [Related]
17. Decreased FAM107A Expression in Patients with Non-small Cell Lung Cancer. Pastuszak-Lewandoska D, Czarnecka KH, Migdalska-Sęk M, Nawrot E, Domańska D, Kiszałkiewicz J, Kordiak J, Antczak A, Górski P, Brzeziańska-Lasota E. Adv Exp Med Biol; 2015 Jul 01; 852():39-48. PubMed ID: 25753555 [Abstract] [Full Text] [Related]
18. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. Agirre X, Román-Gómez J, Jiménez-Velasco A, Garate L, Montiel-Duarte C, Navarro G, Vázquez I, Zalacain M, Calasanz MJ, Heiniger A, Torres A, Minna JD, Prósper F. Oncogene; 2006 Mar 23; 25(13):1862-70. PubMed ID: 16314841 [Abstract] [Full Text] [Related]
19. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome. Mak VC, Lee L, Siu MK, Wong OG, Lu X, Ngan HY, Wong ES, Cheung AN. Mod Pathol; 2011 Apr 23; 24(4):522-32. PubMed ID: 21102414 [Abstract] [Full Text] [Related]
20. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers. Xie XM, Zhang ZY, Yang LH, Yang DL, Tang N, Zhao HY, Xu HT, Li QC, Wang EH. Int J Oncol; 2013 Nov 23; 43(5):1636-42. PubMed ID: 24002585 [Abstract] [Full Text] [Related] Page: [Next] [New Search]